Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Clinical data show that participants on a once weekly subcutaneous injection regimen experienced continuous improvements in glucose control and weight loss outcomes
A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia
It neutralizes harmful free radicals, enhances the immune system, and detoxifies the body
The clinical data behind it is extensive, well-replicated, and remarkably consistent across multiple large-scale trials
US$ 24.44
US$ 22.84
US$ 28.92
